Cancer Research Articles

New treatment option provides lasting relief for men experiencing symptoms of benign prostatic hyperplasia (BPH), also known as an enlarged prostate.

In this newly created senior leadership role, Robey directs all marketing and communications strategies and activities to strengthen the FCS brand and support the company’s long-term growth initiatives.

The study found that 1.05% of participants had developed antibodies against COVID-19 as the result of previous infection, concluding that patients are at low risk for acquiring the coronavirus while receiving care from community oncology providers.

FCS performed strongly in all areas of the survey. Rankings were highest for providers and communication with patients — both of which well exceeded statewide and national averages.

It will provide expanded treatment space for patients, with 18 exam rooms, 50 infusion chairs and on-site imaging, laboratory, pharmacy and care management services. Scheduled to open in November 2021, the 20,250-square-foot building will replace the two existing FCS clinic locations in Manatee County.

Scheduled to open in November 2021, the 20,250-square-foot building will replace the two existing FCS clinic locations in Manatee County.

Innovation proven to minimize potential side effects for prostate cancer patients who receive radiation therapy.

Fort Myers, Fla., Jan. 12, 2021  — Florida Cancer Specialists & Research Institute (FCS) welcomes Board-certified gynecologic oncologist Jessica Stine, MD. She is caring for patients at the FCS New Port Richey location at 8763 River Crossing Blvd., New Port Richey, FL and in Wesley Chapel at 2391 Oak Myrtle Lane, Wesley Chapel, FL.